Susquehanna International Group
PLRX icon

Susquehanna International Group’s Pliant Therapeutics PLRX Stock Holding History

Susquehanna International Group’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$28.6K Sell
22,700
-92,600
-80% -$117K ﹤0.01% 12778
2025
Q4 		$141K Buy
115,300
+58,800
+104% +$88.3K ﹤0.01% 11225
2025
Q3 		$83.6K Sell
56,500
-12,100
-18% -$18.5K ﹤0.01% 11660
2025
Q2 		$79.6K Sell
68,600
-35,300
-34% -$49.9K ﹤0.01% 11914
2025
Q1 		$140K Buy
103,900
+30,200
+41% +$183K ﹤0.01% 11282
2024
Q4 		$971K Buy
73,700
+44,600
+153% +$609K ﹤0.01% 7023
2024
Q3 		$326K Sell
29,100
-46,000
-61% -$576K ﹤0.01% 9418
2024
Q2 		$807K Sell
75,100
-6,700
-8% -$86.4K ﹤0.01% 7096
2024
Q1 		$1.22M Buy
81,800
+69,500
+565% +$1.15M ﹤0.01% 6424
2023
Q4 		$223K Sell
12,300
-4,500
-27% -$68.4K ﹤0.01% 10454
2023
Q3 		$291K Sell
16,800
-131,500
-89% -$2.28M ﹤0.01% 9408
2023
Q2 		$2.69M Buy
148,300
+36,200
+32% +$857K ﹤0.01% 4566
2023
Q1 		$2.98M Buy
112,100
+28,200
+34% +$803K ﹤0.01% 4343
2022
Q4 		$1.62M Sell
83,900
-12,700
-13% -$265K ﹤0.01% 5111
2022
Q3 		$2.02M Buy
96,600
+41,600
+76% +$796K ﹤0.01% 4914
2022
Q2 		$441K Buy
+55,000
New +$352K ﹤0.01% 8582
2022
Q1 		– Sell
-20,600
Closed -$278K – 13745
2021
Q4 		$278K Buy
+20,600
New +$327K ﹤0.01% 10671

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Susquehanna International Group's PLRX Position: Q1 2026 in Review

Susquehanna International Group increased its Pliant Therapeutics (PLRX) stake by 55% in Q1 2026, buying an estimated $23.7K and bringing the position to 52,956 shares worth $66.7K. The position accounts for ﹤0.01% of the portfolio, ranked #12537.

Susquehanna International Group first reported a position in PLRX in Q3 2020 and has held it in 22 quarters since. The position peaked at $15.9M in Q1 2023. 91 funds tracked by Wall St. Rank hold PLRX as of Q1 2026.

  • Susquehanna International Group held 52,956 shares of Pliant Therapeutics worth $66.7K as of Q1 2026.
  • Susquehanna International Group bought 18,755 Pliant Therapeutics shares in Q1 2026, an estimated $23.7K.
  • Pliant Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12537 holding.
  • Susquehanna International Group first reported a position in Pliant Therapeutics in Q3 2020 and has held it in 22 quarters since.
  • Susquehanna International Group's Pliant Therapeutics position peaked at $15.9M in Q1 2023.
  • 91 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.